Abstract
Increasing resistance to fluoroquinolones in uropathogens has become a clinical concern. The purpose of this study was to analyse the urinary bactericidal activity (UBA) of levofloxacin against fluoroquinolone-resistant strains of Escherichia coli. Ten healthy adult subjects (aged 23-60 years) received single doses of levofloxacin (250, 500, 750 and 1000 mg) and then blood and urine samples were collected in intervals (0-1.5, 1.5-4, 4-8, 8-12 and 12-24h) over 24h. Both serum and urine concentrations were measured by a validated high-performance liquid chromatography assay. Bactericidal titres in urine were determined against E. coli isolates with minimum inhibitory concentrations of 0.125, 4, 8, 16, 32 and 64microg/mL for levofloxacin. The mean serum pharmacokinetic parameters for these doses of levofloxacin were similar to previously published values. The mean peak urinary concentrations (0-1.5h) were 210, 347, 620 and 536microg/mL for the 250, 500, 750 and 1000 mg dose, respectively. Each dose of levofloxacin exhibited early (0-1.5h time period) bactericidal activity in urine in virtually all subjects against E. coli strains with MICs<or=32microg/mL. Moreover, high-dose (750 mg and 1000 mg) levofloxacin provided prolonged (8-...Continue Reading
References
Jan 1, 1995·The Journal of Antimicrobial Chemotherapy·R G Masterton, J A Bochsler
Feb 22, 2001·Antimicrobial Agents and Chemotherapy·D XuanC H Nightingale
Jun 13, 2001·Infection and Immunity·M A MulveyS J Hultgren
Jul 4, 2001·Annals of Internal Medicine·K GuptaW E Stamm
Jul 24, 2002·International Journal of Antimicrobial Agents·Niels Frimodt-Møller
Jul 24, 2002·International Journal of Antimicrobial Agents·Kalpana Gupta, Walter E Stamm
Jul 5, 2003·Science·Gregory G AndersonScott J Hultgren
Oct 7, 2003·International Journal of Antimicrobial Agents·Thomas M Hooton
Mar 30, 2004·Antimicrobial Agents and Chemotherapy·Naomi R FloreaDavid P Nicolau
Jun 19, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Thomas M HootonLindsay E Nicolle
Aug 4, 2004·International Journal of Antimicrobial Agents·Gary E Stein, Sharon Schooley
Mar 5, 2005·The American Journal of Medicine·Jeffrey A LinderRandall S Stafford
May 23, 2006·International Journal of Antimicrobial Agents·George G ZhanelDaryl J Hoban
May 26, 2006·Antimicrobial Agents and Chemotherapy·James A KarlowskyGeorge G Zhanel
Sep 26, 2006·The Journal of Antimicrobial Chemotherapy·C A M McNultyM Thomas
Nov 15, 2006·International Journal of Antimicrobial Agents·Florian M E WagenlehnerKurt G Naber
Feb 13, 2007·International Journal of Antimicrobial Agents·Loren G MillerAngela W Tang
Aug 31, 2007·International Journal of Antimicrobial Agents·Florian M E WagenlehnerKurt G Naber
Nov 29, 2007·Clinical Therapeutics·Janet PetersonJames B Kahn
Dec 25, 2007·International Journal of Antimicrobial Agents·Lindsay NicolleGeorge Zhanel
Citations
Nov 5, 2011·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·Y-H ChenP-R Hsueh
Mar 29, 2011·Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi·Po-Ren HsuehYao-Shen Chen
Apr 26, 2013·Expert Opinion on Pharmacotherapy·Cédric RafatAlexandre Hertig
Nov 27, 2016·BMC Infectious Diseases·Eliana S ArmstrongJudith N Steenbergen
Jan 22, 2017·International Urology and Nephrology·Hong RenNan Chen
Sep 7, 2016·Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi·Yun LiYuan Lyu
May 12, 2010·Expert Review of Anti-infective Therapy·Ayman M Noreddin, Walid F Elkhatib
May 24, 2017·The Journal of Antimicrobial Chemotherapy·Thomas MaitreNicolas Veziris
Nov 19, 2010·Postgraduate Medicine·Mazen S BaderAnnie Brooks
May 3, 2019·Journal of Clinical Microbiology·Tam T VanSusan M Butler-Wu
Jan 7, 2021·Antibiotics·Yeonjae KimHyunjoo Pai
Jun 23, 2018·Microbiology Spectrum·Luca GuardabassiScott Weese